In U87MG (an HGF-dependent GBM cell line), IRCR201 showed more potent cancer cell growth inhibition compared to huOA5D5.v2, which has previously been reported to suppress only HGF-dependent cellular proliferation (Figure 5b) [19,20]. The gene discussed is HGF; the disease is glioblastoma.